January 5, 2017
Valneva, Merck in new animal vaccines deal (U.S.&Canada)
Valneva has given Merck in United States and Canada rights to use its EB66 technology to research new veterinary vaccines.
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
January 5, 2017
Futura Medicals launches condom in Saudi Arabia, expects further distribution in MENA
Transdermal technology specialist Futura Medicalis has made an – at least to say – interesting step in Saudi Arabia, country…
January 5, 2017
OptiBiotix replaces Commercial Director
OptiBiotix Health is rearranging its directorial staff as it has changed its Commercial Director. Namely, Jim Laird will be substituted by Per Rehné to that directorial position.
January 5, 2017
Nicox provides clinical and regulatory update for NCX 4251 in blepharitis
Nicox has provided certain regulatory and clinical updates for NCX 4251, its novel ophthalmic suspension of fluticasone propionate nanocrystals being…
January 5, 2017
Neovacs and Professor Robert Kerbel together fight cancer
Neovacs and Professor Robert Kerbel and his team at the Sunnybrook Research Institute of Toronto, Canada are about to join…
January 4, 2017
Bayer nets FDA’s priority review for cancer drug in U.S.
Bayer has started off the new year with another approval from theU.S. Food and Drug Administration (FDA).
January 4, 2017
Sanofi’s type 2 diabetes drug available in U.S.
Sanofi’s Soliqua 100/33 (insulin glargine 100 Units/mL & lixisenatide* 33 mcg/mL injection) is now available by prescription in U.S. pharmacies.
January 4, 2017
J&J’s DePuy Synthes acquires Interventional Spine expandable cage technology
J&J’s DePuy Synthes Products, Inc. has bought asset and signed development agreement with Interventional Spine, Inc., a privately held manufacturer…
January 4, 2017
Eli Lilly’s subsidiary Elanco buys BIVI
Eli Lilly’s subsidiary Elanco US has completed the acquisition of Boehringer Ingelheim Vetmedica, Inc’s (BIVI) U.S. feline, canine and rabies vaccines…
January 4, 2017
FDA said ok to Allergen’s breast implants
Allergan has won FDA’s approval to sell its breast implants in US.